Contact us : info@bioworlde.com
Home > Product > Primary Antibodies
VDR (K45) polyclonal antibody BS3756
  • Western blot (WB) analysis of VDR (K45) polyclonal antibody pAb at 1:500 dilution Lane1:Hela whole cell lysate(30ug) Lane2:HepG2 whole cell lysate(30ug) Lane3:DLD whole cell lysate(30ug) Lane4:NIH-3T3 whole cell lysate(50ug) Lane5:H9C2 whole cell lysate(30ug) Lane6:PC12 whole cell lysate(30ug)
  • Immunohistochemistry (IHC) analyzes of VDR (K45) pAb in paraffin-embedded human breast carcinoma tissue at 1:100.
Product NameVDR (K45) polyclonal antibody
Catalog No.BS3756
Swiss-ProtP11473
Host Rabbit
ReactivityHuman,Mouse,Rat
ApplicationsWB IHC
Application_allWB: 1:500~1:1000_x000D_ IHC: 1:50~1:200
BiowMW~ 48 kDa
Alternative NameVitamin D3 receptor; VDR; 1,25-dihydroxyvitamin D3 receptor; Nuclear receptor subfamily 1 group I member 1; NR1I1
Purification&PurityThe antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen and the purity is > 95% (by SDS-PAGE).
ConjugateUnconjugated
ModificationUnmodification
Browse similar products>>
Size Price
50ul $158
100ul $275
Add to cart My orders
Product Name :
VDR (K45) polyclonal antibody
Background :
The vitamin D receptor (VDR), also known as the calcitriol receptor, and also known as NR1I1 (nuclear receptor subfamily 1, group I, member 1), is a member of the nuclear receptor family of transcription factors. Upon activation by vitamin D, the VDR forms a heterodimer with the retinoid-X receptor and binds to hormone response elements on DNA resulting in expression or trans-repression of specific gene products.It is an intracellular hormone receptor that specifically binds 1,25(OH)2D3 and mediates its effects. Downstream targets of this nuclear hormone receptor are principally involved in mineral metabolism though the receptor regulates a variety of other metabolic pathways, such as those involved in the immune response and cancer.
Product :
Rabbit IgG, 1mg/ml in PBS with 0.02% sodium azide, 50% glycerol, pH7.2
Storage&Stability :
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
Specificity :
VDR (K45) polyclonal antibody detects endogenous levels of VDR protein.
Immunogen :
Synthetic peptide, corresponding to amino acids 11-60 of Human VDR.
Conjugate :
Unconjugated
Modification :
Unmodification
  • Western blot (WB) analysis of VDR (K45) polyclonal antibody pAb at 1:500 dilution Lane1:Hela whole cell lysate(30ug) Lane2:HepG2 whole cell lysate(30ug) Lane3:DLD whole cell lysate(30ug) Lane4:NIH-3T3 whole cell lysate(50ug) Lane5:H9C2 whole cell lysate(30ug) Lane6:PC12 whole cell lysate(30ug)
  • Immunohistochemistry (IHC) analyzes of VDR (K45) pAb in paraffin-embedded human breast carcinoma tissue at 1:100.
Bioworld Biotech only provide peptides for our antibodies and do not provide additional peptide customization services.

Price/Size :

USD 368/1mg/vial



Tips: 

For phospho antibody, we provide phospho peptide(0.5mg) and non-phospho peptide(0.5mg).

Describe :

Blocking peptides are peptides that bind specifically to the target antibody and block antibody binding. These peptide usually contains the epitope recognized by the antibody. Antibodies bound to the blocking peptide no longer bind to the epitope on the target protein. This mechanism is useful when non-specific binding is an issue, for example, in Western blotting (WB) and Immunohistochemistry (IHC). By comparing the staining from the blocked antibody versus the antibody alone, one can see which staining is specific; Specific binding will be absent from the western blot or IHC performed with the neutralized antibody.

Formula:

Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 10 mg/ml.The purity is >90%,tested by HPLC and MS.

Storage:

The freeze-dried powder is more stable. For short time at 2-8°C. For long term storage store at -20°C. 


Note :

This product is for research use only (RUO only). Not for use in diagnostic or therapeutic procedures.
COPYRIGHT © 2015-2018 Bioworld Technology, Inc. All rights reserved POLYCLONAL AND MONOCLONAL ANTIBODY CENTER